FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry and represents a pharmaceutical composition in the form of a coated retard tablet characterised by the fact that it contains a nucleus comprising a nucleus containing trimebutine maleate, microcrystalline cellulose, povidone, hypromellose, magnesium stearate, and a coating that represents Opadry II film (series 85) consisting of partially hydrolysed polyvinyl alcohol, macrogol-3550, titanium dioxide E 171 and talc powder with the ingredients of the composition taken in certain relations, mg.
EFFECT: invention provides storage-stability and high clinical effect.
2 cl, 3 ex
